Related Experiment Video
Updated: May 23, 2026
15:00
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
[Research in pharmacoepidemiology in Iceland]
Magnus Johannsson1, Sigridur Haraldsdottir
1Department of Pharmacology and Toxicology, University of Iceland. magjoh@hi.is
Laeknabladid
|March 31, 2012
Summary
Icelandic databases, including a prescriptions database since 2002, offer powerful tools for pharmacoepidemiology research on drug effects and adverse events. Merged, identifiable data enables long-term studies, encouraging further research in this growing field.
Area of Science:
- Pharmacoepidemiology
- Drug safety research
- Health informatics
Context:
- Iceland has developed comprehensive national databases over decades.
- These databases are crucial for studying drug effects and adverse events.
- Effective pharmacoepidemiological research requires merged, identifiable datasets with long-term data access.
Purpose:
- To provide an overview of Iceland's existing pharmacoepidemiological databases.
- To highlight the importance of personal identification and data merging capabilities.
- To encourage further research utilizing these powerful data resources.
Summary:
- Iceland's databases, particularly the prescriptions database established in 2002, have significantly advanced pharmacoepidemiological research capabilities.
- The utility of these databases is maximized when they contain personal identification allowing for data merging and long-term analysis.
- This review aims to survey available resources and promote their use in studying drug effects and safety.
Impact:
- Facilitates robust, long-term studies on drug efficacy and safety.
- Enhances the potential for discovering previously unknown drug-related effects.
- Supports evidence-based decision-making in public health and clinical practice.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Introduction to Epidemiology
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...